Reliance on pharma a 'significant risk' for Ireland amid tariff dispute

Protectionist measures that impact the biopharma sector, the study said, could lead to Irish job losses, reduced investment, and a reduction in registered intellectual property 

Niall Cunneen:'Our reliance on US pharma for employment and corporate tax creates a significant risk for Ireland's economy.'

Protectionist economic measures coming out of the US could have significant impact on the pharmaceutical sector in Ireland potentially leading to job losses and reduced investment, a new study by a global consultancy group Sia has warned.

Ireland is one of the largest pharmaceutical exporters in the world due to a number of large US pharmaceutical companies operating manufacturing sites in the country. During 2024, Irish exports to the US rose to €72.6bn — of which €44.4bn were from the pharmaceutical and medical sector.